반려동물 백신 시장 : 제품 유형별, 동물 유형별, 유통 채널별, 지역별

Companion Animal Vaccine Market is estimated to be valued at USD 4.09 Bn in 2026 and is expected to reach USD 6.56 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.0% from 2026 to 2033.

Companion animal vaccines play an important role in improving the health of companion animals in a cost effective manner. These vaccines are also important for reducing viral diseases transmitted from animals to animals or animals to humans. The U.S. FDA Center for Veterinary Medicine (CVM) approves drugs for companion (pet) animals such as dogs, cats, and horses and for food-producing animals such as cattle, pigs, and chickens. Moreover, increasing initiatives from regulatory authorities for prevention of diseases such as viral diseases in companion animals are expected to boost the global companion animal market growth over the forecast period. For instance, in 2016, The American Animal Hospital Association (AAHA) has commissioned a task force of veterinary oncology experts to develop a set of guidelines that will help veterinary teams work with pet owners for tailored treatment plans that will improve the quality of life of pets with cancer.

Market Dynamics

The increasing approval and launch of novel companion vaccines, adoption of inorganic growth strategies such as acquisitions and collaborations by key players operating in the market, and rising research and development of novel vaccines are expected to drive the growth of global companion animal vaccine market over the forecast period. For instance, in March 2019, Virbac, a French animal care company, launched a vaccine called CANILEISH to prevent canine leishmaniosis, due to the increasing prevalence of canine leishmaniosis in several regions across the globe, especially in Southern Europe and South America.

Moreover, in June 2018, Zoetis received approval from the U.S. Department of Agriculture for marketing its first monovalent vaccine Fostera Gold PCV, used in the pork industry for swine that includes two genotypes of porcine circovirus type 2 (PCV2).

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global companion animal vaccine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Virbac, Zoetis Inc, HIPRA, Biogenesis Bago, and Ourofino Animal Health.
• Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansions and marketing tactics
• The global companion animal vaccine market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global companion animal vaccine market.

Market Segmentation

• Global Companion Animal Vaccine Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
• Attenuated Live Vaccine
• Conjugate Vaccine
• Inactivated Vaccine
• Subunit Vaccine
• Toxoid Vaccine
• DNA Vaccine
• Recombinant Vaccine
• Global Companion Animal Vaccine Market, By Animal Type (Revenue, USD Bn, 2021 - 2033)
• Canine
• Feline
• Equine
• Others
• Global Companion Animal Vaccine Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
• Veterinary Clinics
• Veterinary Hospitals
• Veterinary Research Institute
• Others
• Global Companion Animal Vaccine Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
• Elanco Animal Health Incorporated
• Boehringer Ingelheim GmbH
• Ceva Ltd.
• Merck & Co. Inc.
• Virbac
• Zoetis Inc.
• HIPRA
• Biogenesis Bago
• Ourofino Animal Health
• Croda International Plc
• KM Biologics
• Indian Immunological Ltd.
• Sinovac
• Kyoto Biken vLaboratories, Inc.
• HESTER BIOSCIENCES LIMITED
• Calier
• Bioveta

Table of Contents

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Species Type
  • Market Snippet, By Distribution Channel
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Product Launches/Approvals
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Companion Animal Vaccine Market, By Product Type, 2021- 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Attenuated Live Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Conjugate Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Inactivated Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Subunit Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Toxoid Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• DNA Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trend
• Recombinant Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trend

5. Global Companion Animal Vaccine Market, By Species Type, 2021- 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Canine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Feline
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Equine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Avians
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends

6. Global Companion Animal Vaccine Market, By Distribution Channel, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Veterinary Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Veterinary Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Veterinary Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Companion Animal Vaccine Market, By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Species Type, 2021 -2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021-2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 -2033, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Elanco Animal Health Incorporated
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Boehringer Ingelheim GmbH
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Ceva Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Merck & Co. Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Virbac
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Zoetis Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • HIPRA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Biogenesis Bago
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Ourofino Animal Health.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Croda International Plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • KM Biologics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Indian Immunologicals Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Sinovac
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Kyoto Biken Laboratories, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • HESTER BIOSCIENCES LIMITED
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Calier
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Bioveta, a.s
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies

9. Section

• References
• Research Methodology
• About us and Sales Contact